Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fruit and vegetables consumption and incident hypertension: dose-response meta-analysis of prospective cohort studies.

Journal of human hypertension·2016
Same author

The predictors of the severity of ischaemic colitis: a systematic review of 2823 patients from 22 studies.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2016
Same author

Economic Evaluation of Primary Prophylaxis Using Filgrastim Versus Pegfilgrastim in Patients With Solid Tumor Cancer: A Systematic Literature Review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

An Analysis of Pricing Premiums Granted Through Submitting Local RCT and Pharmacoeconomics Data in Taiwan.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

An Analysis of the Key Value Drivers for HTA Assessments In Taiwan.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

An Analysis of the Drivers of Pricing Premiums Granted to Innovative Products in Japan.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016

Related Experiment Video

Updated: Jul 11, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Bayesian design for dose-response curves with penalized risk

D Sun1, R K Tsutakawa

  • 1Department of Statistics, University of Missouri-Columbia 65211, USA.

Biometrics
|January 10, 1998
PubMed
Summary
This summary is machine-generated.

This study introduces a Bayesian approach to experimental design in quantal response analysis. A new penalty function helps select designs that minimize information loss and avoid extreme posterior variance, balancing risk and information gain.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

Related Experiment Videos

Last Updated: Jul 11, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

Area of Science:

  • Biostatistics
  • Experimental Design
  • Statistical Modeling

Background:

  • Quantal response analysis is crucial for determining dose-response relationships.
  • Estimating parameters like ED50 requires careful experimental design.
  • Traditional Bayesian design criteria may not account for outcome variability.

Purpose of the Study:

  • To develop a robust Bayesian design strategy for quantal response studies.
  • To address the limitations of using predicted posterior variance alone for design selection.
  • To propose a method that safeguards against experiments yielding minimal information.

Main Methods:

  • Bayesian design principles applied to quantal response analysis.
  • Introduction of a novel penalty function to manage posterior variance.
  • Numerical simulations to evaluate design performance under the logistic model.

Main Results:

  • Predicted posterior variance is insufficient for optimal design selection.
  • The proposed penalty function effectively reduces the chance of extreme posterior variance.
  • Designs incorporating the penalty function offer a favorable trade-off between Bayes risk and information certainty.

Conclusions:

  • A refined Bayesian design approach enhances experimental reliability in quantal response studies.
  • The penalty function provides a practical tool for experimenters to mitigate risks associated with information variability.
  • This method aids in selecting experimental designs that are both informative and robust to unexpected results.